Clinical Trial

Therapy, Excision and Observation for Early Rectal Cancer

Study Description

NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer

The purpose of this study is to find out the effects of chemotherapy followed by less invasive surgery on patients and their early rectal cancer. The approach of this trial will be considered a success if at least 65% of participants are able to keep the rectum.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - Folfox Protocol

6 cycles of q2weekly FOLFOX, or

Drug - Capox

4 cycles of q3weekly CAPOX

Additional Information

Official Study Title

NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer

Clinical Trial ID

NCT03259035

ParticipAid ID

zbq4ra